Journal
RADIOTHERAPY AND ONCOLOGY
Volume 70, Issue 1, Pages 31-36Publisher
ELSEVIER SCI IRELAND LTD
DOI: 10.1016/j.radonc.2003.10.013
Keywords
stereotactic radiotherapy; stereotactic body frame; dose escalation; boost irradiation; tumor recurrences
Ask authors/readers for more resources
Based on the experience of stereotactic irradiation of lung and liver tumors the feasibility of stereotactic boost irradiation to abdominal and pelvic tumors was evaluated. Twenty-one patients with inoperable tumors received a stereotactic boost of 2-3 X 5 Gy/PTV-enclosing-100% isodose with normalization to 150% at the isocenter after normofractionated irradiation of 45-50.4 Gy. Actuarial local control (16/21 targets) was 96/70% after 12 and 24 months. Treatment was feasible and well tolerated. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
